Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

10 Nov 2014 07:00

RNS Number : 5259W
Kingspan Group PLC
10 November 2014
 

Kingspan Group Plc

Interim Management Statement

 

10 November 2014

 

Kingspan Group plc, the global leader in high performance insulation and building envelopes, today issues the following Interim Management Statement, with trading information for the period from 1 July to 30 September 2014.

 

Sales in the nine month period to 30 September were €1.39bn, up 5% on the prior year (+5% constant currency). A solid sales performance was also recorded in the third quarter with revenue up 7% (+5% constant currency) compared to the same period in 2013.

Insulated Panels revenue in the first nine months increased by 9% (+9% constant currency), and by 8% (+7% constant currency) in the third quarter. The UK continued to perform well with encouraging activity across most building segments. After a sluggish second quarter sales performance, Mainland Europe remained weak through the third quarter reflecting somewhat of an abatement in German market activity. The pace of sales growth in North America improved in the third quarter helped by a strong order book as we entered the second half. Order intake also showed a significant improvement over prior year. Activity in Australasia continued the strong trend evident in the first half.

Insulation Board revenue in the first nine months was up 3% (+1% constant currency) compared with the same period last year, and ahead by 6% in quarter three (+2% constant currency). The UK sales performance was positive through the third quarter, and Mainland European sales were relatively stable overall year on year. Further progress in market conversion was evident in Australia during the third quarter.

Environmental revenue in the first nine months was ahead of last year by 1% (-2% constant currency) and by 3% (-3% constant currency) in the third quarter, continuing on the path of relative stabilisation seen earlier in the year.

Access Floors revenue in the first nine months was 4% behind the same period last year (-4% constant currency). Sales in the third quarter were ahead by 11% (+8% constant currency) with continuing momentum evident in UK office construction activity and an improvement in the US relative to a weak first half.

 Net debt at the end of September 2014 was €107.7m, €39.1m lower than at the same point in 2013. The fourth quarter is a seasonally cash generative period and this would indicate net debt levels by year end in the region of €140m after taking account of the acquisitions of Pactiv Insulation (North America) and PAL (UAE). These insulation board businesses were separately acquired in October for a combined consideration of €77m.The relative optimism that prevailed earlier in the year appears to have waned in recent months, particularly in Europe. Whilst our business continues to perform solidly, we nonetheless are mindful of what are currently more tempered 2015 economic forecasts, and remain focused on driving the Kingspan proposition, whatever the macro climate.

The fourth quarter of 2013 was particularly strong for the Group. Notwithstanding that, and with this seasonally important and often variable period to come, we expect to deliver a full-year trading profit in the region of €144m (+17% versus 2013).

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBGUGBGSR
Date   Source Headline
1st Nov 20193:33 pmRNSTotal Voting Rights
1st Oct 20193:31 pmRNSTotal Voting Rights
24th Sep 20195:38 pmRNSHolding(s) in Company
17th Sep 20195:41 pmRNSHolding(s) in Company
2nd Sep 20191:04 pmRNSTotal Voting Rights
23rd Aug 20197:00 amRNSHalf-year Report
23rd Aug 20197:00 amRNSEuronext Dublin Market Notice
22nd Aug 20193:13 pmRNSHolding(s) in Company
19th Aug 20193:00 pmRNSBlock Listing Application
8th Aug 20199:22 amRNSHolding(s) in Company
11th Jul 20193:38 pmRNSHolding(s) in Company
1st Jul 20195:35 pmRNSBlock listing Interim Review
1st Jul 20193:14 pmRNSTotal Voting Rights
1st Jul 201910:41 amRNSCorporate Broker Appointment
19th Jun 20193:57 pmRNSDirector/PDMR Shareholding
18th Jun 20195:25 pmRNSDirector/PDMR Shareholding
5th Jun 20194:52 pmRNSDirector/PDMR Shareholding
4th Jun 20191:04 pmRNSTotal Voting Rights
4th Jun 201910:33 amRNSHolding(s) in Company
21st May 201910:30 amRNSDirector/PDMR Shareholding
20th May 20197:00 amRNSHolding(s) in Company - REPLACEMENT
17th May 20194:20 pmRNSDirector/PDMR Shareholding
17th May 20194:16 pmRNSHolding(s) in Company
9th May 20195:46 pmRNSDirector/PDMR Shareholding
9th May 20195:46 pmRNSDirector Declaration
7th May 20195:07 pmRNSResult of AGM
7th May 20193:42 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSAGM Statement
1st May 201910:37 amRNSTotal Voting Rights
26th Apr 20197:15 amRNSStatement re Recticel NV/SA
16th Apr 201910:15 amRNSStatement re Recticel NV/SA
1st Apr 20195:13 pmRNSTotal Voting Rights
27th Mar 20194:40 pmRNSHolding(s) in Company
27th Mar 20192:39 pmRNSDirector/PDMR Shareholding
19th Mar 201910:27 amRNSHolding(s) in Company
14th Mar 201912:36 pmRNSDirector/PDMR Shareholding
13th Mar 201910:01 amRNSChange of Adviser
5th Mar 201912:30 pmRNSAnnual Financial Report
4th Mar 20193:52 pmRNSHolding(s) in Company
1st Mar 20194:16 pmRNSTotal Voting Rights
26th Feb 20199:45 amRNSDirector/PDMR Shareholding
22nd Feb 20197:00 amRNSFinal Results
18th Feb 201911:22 amRNSHolding(s) in Company
14th Feb 20195:43 pmRNSHolding(s) in Company
8th Feb 20193:02 pmRNSHolding(s) in Company
4th Feb 20194:27 pmRNSHolding(s) in Company
23rd Jan 20195:35 pmRNSHolding(s) in Company
11th Jan 201912:51 pmRNSHolding(s) in Company
2nd Jan 201910:30 amRNSBlock listing Interim Review
2nd Jan 201910:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.